About Us

Home

About

About Us

Bridging Innovation and Commercialisation in MedTech

Fusara is a strategic MedTech development and commercialisation partner based in Australia, with deep operational networks in India.
Australia produces world-class medical innovation and intellectual property, but many MedTech start-ups fail when they shouldn’t.

The Problems We Address

Key challenges faced by Australian Medtech start-ups include:

High development and clinical trial costs

Small trial cohorts in mature markets

Difficulty raising capital for FDA / TGA approval

Inefficient use of limited funding

Lack of execution expertise beyond early R&D

Fusara addresses these challenges by enabling early market fit validation, cost-efficient clinical trials, and scalable manufacturing pathways

Our Approach

Bridging Australia and India for MedTech Synergy

Australia Provides:

World-class research, innovation, and IP

Strong regulatory frameworks

Clinical excellence

India Provides:

Cost-efficient, globally accepted clinical trials

Large and diverse patient populations

Many world-class private hospitals

Advanced manufacturing and engineering capability

Expanding MedTech parks, universities, and innovation hubs

Fusara integrates both ecosystems to reduce risk, cost, and time to market

What We Do

Fusara supports MedTech companies across critical stages:

Clinical evaluation and early market fit validation

Access to private hospitals, clinicians, and trial subjects

Established CRO, university, and government relationships

Prototype development and design for scale manufacturing

Regulatory alignment

Our model focuses on execution, not just advice.

Primary focus is on non-invasive medical devices.

Focused on early market fit and capital efficiency, particularly for non-invasive medical devices

Why India for Early Market Fit

A Strategic Advantage for Early Market Fit

Supportive clinicians in large world-class private hospital networks

Costs are significantly lower than in Australia and the US

Faster iteration and learning cycles

Real-world clinical data improves investor confidence

Globally accepted regulatory standards (FDA/TGA/EU aligned)

Early validation of market fit in India reduces downstream risk and avoids costly pivots later

How We Work

Fusara is not an accelerator, incubator, or venture capital firm.

We operate as a strategic partner, offering:

Engagement Models

Fee-for-service or equity-based engagement, tailored to your needs.

Joint Ventures & Licensing

Flexible joint ventures or licensing models to maximize impact.

Operational Support

Long-term operational and execution support for scaling.

Milestone Governance

Transparent, milestone-based governance aligned with client success.

How We Work With

Ideal clients:

Strategic interest in India & Asia markets as a precursor or parallel path to Australia & US strategies

MedTech founders seeking genuine partnership

Strong potential to progress to clinical trials and commercialisation

Focused on early market fit and capital efficiency

contact@fusara.com.au

© 2026 Fusara | All Rights Reserved